Advancing personalized care in hemophilia A: ten years’ experience with an advanced category antihemophilic factor prepared using a plasma/albumin-free method

Detailed analysis of data from studies of recombinant antihemophilic factor produced using a plasma/albumin-free method (rAHF-PFM) in previously treated patients showed a substantial level of interpatient variation in pharmacokinetics (PKs), factor VIII dosing, and annualized bleed rate (ABR), sugge...

Descripción completa

Detalles Bibliográficos
Autores principales: Berntorp, Erik, Spotts, Gerald, Patrone, Lisa, Ewenstein, Bruce M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984057/
https://www.ncbi.nlm.nih.gov/pubmed/24741292
http://dx.doi.org/10.2147/BTT.S53456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984057/
https://www.ncbi.nlm.nih.gov/pubmed/24741292
http://dx.doi.org/10.2147/BTT.S53456

Ejemplares similares